DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes

DexCom (DXCM) recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use glucose data from Dexcom G7 Continuous Glucose Monitoring Systems (CGM) synchronously alongside Nanowear's previously FDA-cleared cardiovascular biomarkers for investigational purposes. With this recent deal, DexCom continues to strengthen its leadership in CGM integration. This collaboration also aligns with the com ...